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INTRODUCTION
As cancer treatments improve and people 
live longer, the number of individuals living 
with, and beyond, cancer is increasing. More 
than 80% of children and adolescents, and 
50% of adults diagnosed with cancer, will 
survive for ≥5 years after completing their 
cancer treatment.1,2 There are currently 
>14.5 million US and 2 million UK survivors 
of cancer, equating to about 3% of each 
population; over the next decade these 
numbers are expected to grow to 19 million 
and 3 million respectively.3,4
Traditionally, follow-up care has 
been provided by cancer specialists and 
has mainly focused on monitoring for 
recurrence and second primary cancers. 
With the number of survivors of cancer 
growing dramatically, a model of care 
led purely by secondary care is clearly no 
longer feasible;5 a more holistic approach is 
also needed. Integrated models of care are 
warranted, as when care is shared between 
secondary and primary care, or in models 
in which primary care takes over the care 
of patients who are stable earlier than 
currently happens. The National Cancer 
Survivorship Initiative (NCSI) has proposed 
a risk-stratified approach, whereby those 
at low risk are supported to self-manage 
in the community, those at high risk are 
managed by specialist teams, and care 
for those at moderate risk is shared by 
secondary and primary care.6
Many survivors of cancer are at risk of 
chronic morbidity and premature mortality 
as a consequence of their cancer and its 
treatment.7 Some of these consequences 
present during, or soon after, active 
treatment and can persist for many years. 
They include:
• chronic fatigue;
• persistent pain;
• mental health problems;
• sexual dysfunction; and
• urinary and gastrointestinal problems.8
Others are considered to be ‘late effects’, 
due to the cancer and its treatment. These 
may include bone, pulmonary, renal, or 
neurological toxicities, and there is also 
increasing evidence that cardiovascular 
health can be affected by many types of 
cancer treatment. As an example, following 
childhood cancer treatment, people are 
five times more likely to develop congestive 
heart failure and myocardial infarction 
compared with their siblings.9,10
As many as 500 000 UK survivors of 
cancer are considered to be experiencing 
consequences attributable to cancer 
treatment,4 yet there is evidence that many, 
particularly adult survivors of childhood 
cancer, do not receive appropriate generalist 
or specialist care that focuses on the risks 
arising from their prior cancer therapy.11
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Abstract
Background 
Increasing numbers of people are living with, 
and beyond, cancer. They are at risk of long-
term morbidity and premature mortality due 
to the consequences of their disease and its 
treatment. Primary care can contribute to 
providing ongoing care.
Aim
To determine the current practice and views of 
GPs in England regarding cancer survivorship 
care.
Design and setting
Online survey of a sample of 500 GPs, stratified 
by NHS region in England.
Method
The survey included questions adapted from 
prior surveys assessing physician knowledge and 
attitudes regarding care of patients with cancer. 
Results
In total, 500 GPs responded; approximately half 
reported often providing care to people living 
beyond cancer for treatment-related side effects 
(51%), psychological symptoms (65%), and 
lifestyle advice (55%). Only 29% felt very confident 
managing treatment-related side effects 
compared with 46% and 65% for psychological 
symptoms and lifestyle advice respectively. Half 
reported usually receiving cancer treatment 
summaries and survivorship care plans but 
most of the sample felt these would improve 
their ability to provide care (76%). Only 53% 
were convinced of the usefulness of cancer care 
reviews. Although most felt that primary and 
specialist care should share responsibility for 
managing bone (81%) and cardiovascular (77%) 
health consequences, fewer than half reported 
often taking previous history of cancer or cancer 
treatment into consideration when assessing 
bone health; only one-fifth did this in relation to 
cardiovascular health. Most responders were 
interested in receiving education to improve their 
knowledge and expertise.
Conclusion
GPs have a potentially important role to play in 
caring for people following cancer treatment. 
This study has highlighted areas where 
further support and education are needed to 
enable GPs to optimise their role in cancer 
survivorship care.
Keywords
cancer; follow up-care; general practitioners; 
primary health care; survivors; views.
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Over the last decade an international focus 
on cancer follow-up has begun to recognise 
these unmet needs of survivors of cancer.5,12 
Experts have advocated the value of sharing 
survivorship care between specialists 
and primary care, and there is increasing 
evidence that, as well as preventive care, 
such as advice around physical activity and 
healthy weight management,13 follow-up 
care for some cancers can be provided 
as safely and effectively in primary as in 
secondary care.14,15 In the UK, primary care 
is potentially well placed to undertake this 
work, with its universal system of patient 
registration, generalist skills, and high 
satisfaction ratings. 
The 2012 UK NCSI promoted a ‘recovery 
package’ that included a cancer treatment 
summary for patients and their GPs. It 
detailed possible treatment toxicities, late 
effects, and alert symptoms requiring 
referral back to specialist care, along with 
an ongoing management plan.16,17 It also 
recommended a survivorship care plan, 
a structured holistic needs assessment 
aiming to help assessment and monitoring, 
and a cancer care review to be undertaken 
by a GP within 6 months of their patient’s 
cancer diagnosis. This should be encouraged 
through inclusion in the general medical 
services Quality and Outcomes Framework.18
Against this background of recent 
recommendations, the aim of this study 
was to examine the current practices and 
views of GPs in England on providing care 
for those living with, and beyond, cancer. 
The researchers were interested in GPs’ 
experiences, knowledge, and views in 
relation not only to caring for people who 
have recently completed active cancer 
treatment, but also to caring for people living 
beyond cancer treatment in general, and in 
relation to cardiovascular and bone health 
after cancer specifically. 
METHOD
Participants
A questionnaire was distributed 
electronically via Medix, a leading market 
research consultancy specialising in high-
quality online research using pre-recruited 
panels of medical professionals. At the 
time of recruitment, the UK GP panel size 
was approximately 10 000. Sampling was 
restricted to currently practising GPs, was 
stratified by NHS region, and was conducted 
on a ‘first come, first served’ basis; the 
target number of responses was 500. 
Recruitment started in mid-June 2014 
and continued for 4 weeks, when the 
target number of responses was reached. 
Potential participants were sent an e-mail 
explaining the purpose of the study and a 
web link to the survey; entry into a prize 
draw for taking part was also offered.
Survey instrument
The survey (available from the authors on 
request) was adapted from prior surveys 
assessing physician knowledge and 
attitudes regarding care of patients with 
cancer,19,20 and also included new questions 
generated specifically for this study and 
informed by expert opinion. It comprised 
25 questions focused on follow-up care 
for survivors of cancer, who were defined 
as ‘people living with, and beyond, cancer 
(excluding non-melanoma skin cancer) or 
those who have completed definitive primary 
cancer treatment’.21 Quantitative survey 
items utilised ‘yes/no’ responses and five-
point Likert scales. The questionnaire was 
piloted with non-academic GP colleagues 
(n = 6) to ensure face validity. No questions 
were removed or added in this process but 
the wording of some items was slightly 
modified in response to their feedback. For 
example, ‘further training’ was changed to 
‘further learning opportunity’ and the word 
‘diminished’ when referring to ‘diminished 
cardiovascular or bone health’ was 
amended to ‘reduced’.
The survey sought information about GP 
demographics, experience, workload, and 
practice type Responders were asked: 
• about their management of people who 
had recently completed active cancer 
treatment, including how often they 
received cancer treatment summaries 
and survivorship care plans from hospital 
specialists, and what information was 
included;
How this fits in
As many as 500 000 survivors of 
cancer in the UK are considered to be 
experiencing consequences attributable 
to cancer and its treatment. Despite 
recent recommendations, only half the 
surveyed GPs in England reported usually 
receiving cancer treatment summaries 
and survivorship care plans, and fewer 
took a previous history of cancer or 
cancer treatment into consideration when 
assessing bone or cardiovascular health. 
The findings suggest that interventions 
should focus on improving communication 
between specialist and primary care, 
raising GP awareness of physical and 
psychological consequences, and 
enhancing GP knowledge of late effects of 
cancer treatment.
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• how often they provided specific care 
for these people, including management 
of treatment-related side effects, 
psychological symptoms, lifestyle factors, 
and advice concerning work and finances, 
and how confident they felt in this role; 
• how frequently they conducted cancer 
care reviews, whether they found them 
useful, and how they were undertaken, 
including the use of templates;
• how often they were aware that a patient 
had been diagnosed with cancer within 
5 years, 5–10 years ago, and >10 years 
ago;
• about their awareness of possible 
late cardiovascular and bone effects 
following treatment, and their opinion 
on who should be responsible for the 
management of these possible treatment 
consequences; and
• about training they had undertaken and 
would like to receive in this area. 
The questionnaire included one open-
ended question that allowed responders to 
provide comments about the training they 
had undertaken. 
Statistical analysis
Participants entered their survey responses 
online. Descriptive statistics were used 
to report practitioner characteristics, 
frequencies of current practice, and 
knowledge and training items. When 
comparing how often they considered a 
diagnosis of cancer, the responses were 
dichotomised into ‘never’, ‘rarely’, and 
‘sometimes’ versus ‘often’. For their 
knowledge of associations between 
cancer treatment and reduced health, 
the proportion correctly answering each 
question was compared with those who 
answered incorrectly or did not know. 
Reported modes of previous cancer 
education were grouped into categories: 
• self-directed learning (reading, 
e-learning, consultant letters, or hospice 
newsletters);
• attending meetings or lectures; 
• more formal courses (GP Update, or 
diploma course); and 
• clinical attachments. 
McNemar’s test was used to compare 
how often GPs considered a diagnosis of 
cancer when assessing cardiovascular or 
bone health, and logistic regression when 
comparing which features are associated 
with finding cancer care reviews useful. 
All analyses were performed using Stata 
(version 12). Results are presented as odds 
ratios (ORs) and 95% confidence intervals 
(CIs). Statistical significance was set at 
P = 0.05. 
RESULTS
Participant characteristics
Participant characteristics are shown in 
Table 1. There were 500 GP responders, who 
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Table 2. Care for people who recently completed active cancer 
treatment
Rarely/never/
don’t know,a 
n (%)
Sometimes, 
n (%)
Often/almost 
always,a 
n (%)
How often the GPs receive:
A short treatment summarya 38 (7.6) 114 (22.8) 348 (69.6)
A detailed treatment summarya 89 (17.8) 160 (32.0) 251 (50.2)
Details of ongoing care from hospitala 63 (12.6) 152 (30.4) 285 (57.0)
Details of ongoing care to be provided by GPa 133 (26.6) 157 (31.4) 210 (42.0)
Information on when to refer backa 231 (46.2) 165 (33.0) 104 (20.8)
Information on possible late effectsa 291 (58.2) 130 (26.0) 79 (15.8)
Frequency of providing care related to:
Management of treatment-related side effects 61 (12.2) 182 (36.4) 257 (51.4)
Management of psychological symptoms 57 (11.4) 164 (32.8) 279 (55.8)
Lifestyle health care 41 (8.2) 183 (36.6) 276 (55.2)
Advice concerning work and/or finances 146 (29.2) 204 (40.8) 150 (30.0)
a‘Almost’ always was provided as an option in place of ‘don’t know’ for these questions. The options were rarely/
never/sometimes/often/almost always, whereas the options for the other questions were rarely/never/don’t know/
sometimes/often.
Table 1. Characteristics of 
participants (n = 500) 
Characteristic n (%)
Sex
Male 377 (75)
Female 123 (25)
Experience, years
<5 5 (1)
5–10 34 (7)
10–15 96 (19)
>15 365 (73)
Type of GP
Partner 397 (79)
Salaried GP 75 (15)
Locum 25 (5)
Trainee 2 (0.4)
Trainer 117 (23)
Macmillan GP 9 (2)
GP practice
Urban 269 (54)
Rural 78 (16)
Mixed 153 (31)
GP workload
Half time (≤4 sessions/week) 63 (13)
Three-quarter time  
(5–7 sessions/week)
168 (34)
Full-time (≥8 sessions/week) 269 (54)
were drawn fairly equally from across the 
10 NHS regions (East of England, London, 
South Central, North East, North West, 
Yorkshire and the Humber, East Midlands, 
West Midlands, South East Coast, and South 
West). GPs ranged from 37–59 (7–11%) 
per region. There were more male (75%) 
than female responders; most were GP 
partners in primary care practice (79%) with 
>15 years’ experience (73%). Just over half 
were working full time (54%) and almost 
one-quarter were GP trainers (23%). 
In this study, the participants comprised 
more male GPs, GP partners, and trainers, 
and fewer full-time workers, than the 
national average: 49% of GPs in England 
are male, 66% are GP partners, 16% are 
trainers, and 71% work full-time.22,23
Recent active cancer treatment
Approximately half of the GP responders 
reported often/almost always receiving a 
detailed cancer treatment summary, details 
of ongoing care from the hospital, or details 
of ongoing care to be provided by the GP. 
Only one-fifth often received information on 
when to refer back specialist care, and just 
under one-sixth received information on 
late effects (Table 2). Half the GPs reported 
often providing care relating to treatment-
related side effects (51%), psychological 
symptoms (56%), and lifestyle (55%), but 
fewer often gave advice concerning work 
and/or finances (30%). This was reflected 
in their reported confidence in providing 
these aspects of care: GPs were most 
confident providing lifestyle advice or 
managing psychological symptoms and 
least confident managing work or financial 
issues (P<0.0005) (Figure 1).
Most GPs felt that the provision of 
standardised cancer treatment summaries 
and survivorship care plans would improve 
their ability to provide care (n = 380, 76%); 
only a few felt they would not help (n = 17, 
3%) and some were unsure (n = 103, 21%) 
(data not shown). 
Similar numbers of GPs conducted 
cancer care reviews opportunistically and 
by offering a specific review appointment 
with themselves or their practice nurse 
(Table 3). Forty per cent used a template, 
mostly developed locally. However, only 
half of responders felt the cancer care 
review was useful (53%), with a few feeling 
it was not useful (10%). GPs who used 
a template, along with those who made 
specific appointments for cancer care 
reviews, were more likely to report that 
it was useful/very useful than those who 
did not use a template (OR 1.48 [95% CI 
=1.02 to 2.12], P = 0.035) or completed 
them opportunistically (OR 3.27 [95% CI = 
2.20 to 4.86], P<0.0005) (data not shown). 
The effect of having specific appointments 
remained significant after adjustment for 
use/no use of a template (OR 3.20 [95% CI 
= 2.15 to 4.77], P<0.0005) (data not shown). 
Care beyond cancer treatment
Most GPs reported they would be aware 
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Figure 1. GP confidence in provision of 
specific care to patients who recently 
completed cancer treatment, by care type.
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Table 3. Cancer care reviews: 
current practice and views
Conduct n (%)
Opportunistically, face to face 225 (45)
By offering a specific appointment with 
a GP
206 (41)
By offering a specific appointment with a 
practice nurse
13 (3)
By telephone 39 (8)
Never done/don’t know 17 (3)
Use of a template in a cancer care reviewa
No 301 (60)
Yes 199 (40)
The Macmillan template 8 (2)
A template provided by local 
clinicians or CCG
82 (16)
A template developed in the practice 91 (18)
Don’t know 18 (4)
Usefulness
Not useful 48 (10)
Not sure 187 (37)
Useful 219 (44)
Very useful 46 (9)
CCG = clinical commissioning group. aFive hundred 
GPs answered ‘yes’ or ‘no’; 199 answered ‘yes’ to use 
of a template .
if a consulter had had a cancer diagnosis 
within 5 years (92%) of the consultation; 
however, this fell to about half when the 
cancer diagnosis had taken place >10 years 
previously (55%) (Figure 2). 
Although most GPs reported 
knowledge of associations between types 
of cancer treatment and reduced bone 
health (hormone therapy n = 417, 83%; 
chemotherapy n = 338, 68%; radiotherapy 
n = 290, 58%), fewer reported knowledge 
of similar associations with reduced 
cardiovascular health (hormone therapy 
n = 267, 53%; chemotherapy n = 249, 50%; 
radiotherapy n = 200, 40%). Additionally, 
fewer than half of the GPs reported often 
considering a previous history of cancer 
or cancer treatment when assessing bone 
health; this was significantly less when 
assessing cardiovascular health (n = 198, 
40% versus n = 104, 21% respectively, OR 
4.76 [95% CI = 3.07 to 7.64], P<0.001) (data 
not shown). 
Although only half of the GPs (n = 252, 50%) 
felt often/almost always clear about their 
role providing care to people living beyond 
cancer, most believed that secondary and 
primary care working together should be 
responsible for managing cardiovascular 
and bone health (n = 385, 77% and n = 406, 
81% respectively). Some GPs believed it 
should be primary care alone (n = 101, 20% 
and n = 76, 15% respectively), and fewer 
than 3% opted for secondary care alone 
(data not shown).
Training, education, and knowledge
Half the GPs (n = 250, 50%) reported 
having some previous training in general 
care of people after cancer treatment. 
Just under one-third had also had some 
training specifically related to bone or 
cardiovascular health (n = 158, 32% and 
n = 107, 21% respectively). Of all those GPs 
who reported having any previous training 
(n = 274), most had either undertaken self-
directed learning (n = 113, 41%) or attended 
meetings or lectures (n = 84, 31%). A small 
number had completed courses (n = 35, 
13%) or clinical attachments (n = 25, 9%) 
(data not shown).
Most GPs were keen to undertake 
further education on cardiovascular (86%) 
and bone (82%) consequences following 
treatment, and the management of 
treatment-related side effects (76%). Fewer 
felt that they needed further education 
in the management of psychological 
symptoms (52%), advice concerning work 
and/or finances (36%), or lifestyle health 
care (23%) (Table 4).
DISCUSSION
Summary
These findings show that the GPs 
surveyed were generally confident 
managing treatment-related side effects 
and psychological symptoms, as well as 
providing lifestyle advice for people who 
have recently completed active cancer 
treatment. They were less confident giving 
advice concerning work and finances, and 
provided this information less frequently. 
The GPs felt that more information 
and communication in the form of cancer 
treatment summaries and survivorship 
care plans would improve their ability 
to provide quality cancer care. Although 
most were providing cancer care reviews, 
more than half of these are undertaken 
opportunistically or via telephone 
consultations and without using templates, 
and just over one-third of GPs were 
uncertain about their usefulness. 
Most felt that primary and specialist 
care could jointly manage bone and 
cardiovascular health consequences. 
However, many reported being unaware 
of a previous diagnosis of cancer and 
did not routinely consider a previous 
history of cancer when assessing bone 
or cardiovascular health. Encouragingly, 
most GPs had an appetite for further 
education to improve their knowledge 
and expertise about the management of 
cancer treatment-related side effects and 
cardiovascular and bone consequences.
Strengths and limitations 
Using an established research company 
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Figure 2. GPs’ awareness of cancer diagnosis.
Table 4. Areas of desired 
further education
Area n (%)
Management of cardiovascular 
consequences following treatment
430 (86)
Management of bone consequences 
following treatment
411 (82)
Management of treatment-related side 
effects
381 (76)
Management of psychological 
symptoms
260 (52)
Advice concerning work and/or finances 180 (36)
Lifestyle health care 116 (23)
Never/Don’t know/Rarely Sometimes Often/Almost always
When the cancer 
diagnosis was within 
5 years
When the cancer 
diagnosis was 
>10 years ago
When the cancer 
diagnosis was 
between 5–10 years
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enabled the views of GPs across each 
NHS region in England to be sampled, 
and a large sample of 500 responders was 
achieved. However, these participants are 
drawn from a group of GPs interested in 
taking part in research and, as such, may 
not be entirely representative of GPs in 
England. The sample also included more 
male GPs, GP partners, and trainers, and 
fewer full-time GPs, than the national 
average. The findings should, therefore, 
be generalised to national level with some 
caution. Furthermore, the survey may be 
susceptible to response bias; for example, 
it could be that better-educated GPs or 
those with a greater interest in the care 
of survivors of cancer were more likely to 
respond. In addition, the findings on current 
practice are self-reported and may differ 
from actual behaviour.
Comparison with existing literature
Despite the efforts of the recent NCSI 
strategies, the findings presented here 
are not substantially improved from 
those reported following a similar, but 
smaller, online survey of GPs in England 
(n = 200) conducted in 2009;19 there was no 
improvement in the proportion conducting 
a cancer care review opportunistically 
rather than routinely.
There was also little improvement in 
the communication from expert care, 
particularly at the completion of active 
cancer treatment, and similar findings 
have been found in North American 
surveys of primary care physicians.20,24,25 
This is despite evidence that interventions 
improving communication between primary 
and secondary care have been shown to 
increase GP involvement in cancer care.26
Most responders reported a willingness 
to accept either shared or sole responsibility 
for the routine follow-up care of their 
patients; primary care physicians in North 
America27 and GPs in the Netherlands28 
have demonstrated similar attitudes. Some 
studies have only identified this willingness 
when the GPs were provided with a 
survivorship care plan, or in consultation 
with a long-term specialist follow-up 
programme.11,29 However, most studies 
in this area have focused on caring for 
people as they complete treatment for 
breast or colorectal cancer. It may be that 
GP willingness depends on the specific 
type of cancer, its complexity, and the 
type of the follow-up tests required; for 
instance, GPs may have more concerns 
about caring for survivors of childhood 
cancer.11 A number of studies have also 
reported disagreement between GPs and 
oncologists regarding the ideal model of 
follow-up care, with some oncologists not 
favouring increased GP involvement30 and 
some GPs preferring main responsibility to 
remain with oncologists.31 These attitudinal 
barriers could impede implementation of 
new models of shared care, but may be 
more prevalent in healthcare systems such 
as that in the US.30
The willingness of GPs to work more 
closely with secondary care on the follow-
up role may also be hampered by a 
perceived lack of specialist knowledge.14 In 
contrast with the earlier English survey,19 
this study found an enthusiasm for further 
training, particularly around the impact of 
late effects of cancer treatment on bone 
and cardiovascular health. This may be 
due to the recent influence of the NCSI in 
the UK — this contrasts with reports from 
North America where, although primary 
care physicians desire to be closely involved 
in delivering survivorship care, many felt 
unprepared to both evaluate and manage 
the long-term effects of their survivors of 
cancer.11,20
The resonance of the study findings with 
results from similar surveys undertaken in 
North America and Western Europe also 
suggests that the issues around caring 
for people living with, and beyond, cancer 
are universal. Against the backdrop of 
increasing and ageing populations, along 
with improved cancer detection and 
treatment, patients are living with their 
disease for longer. A recent editorial in 
Lancet Oncology suggested that ‘provision 
for cancer patients [is] a priority in primary 
care reforms’,32 and highlighted the need 
for more patient-centred and integrated 
primary and secondary care. This is 
supported by the results of this study, in 
which almost all GPs (97%) agreed that 
primary care should play a role in the care 
of patients living beyond cancer, and many 
felt increased communication between 
primary and secondary care would improve 
their ability to provide quality cancer care. 
Implications for practice
Better dissemination of currently available 
survivorship care resources would 
encourage their systematic application.20 
Timely use of cancer treatment summaries 
would enhance communication between 
specialist and generalist care, and 
appropriate development of survivorship 
care plans would enhance a patient-centred 
approach. Optimising the utility of current 
cancer care reviews by encouraging the 
development of local templates and planned 
appointments may also enable GPs to feel 
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more confident about their role, and would 
usefully provide an opportunity for patients 
to discuss their future care with their GP. 
This could be achieved by encouraging GP 
practices to adopt a proactive, rather than 
reactive, approach to cancer care reviews, 
through the development of local templates; 
this appeared to be favoured by GPs as well 
as by specialists encouraging patients to 
make an appointment to see their GP at 
the point of discharge after completion of 
treatment.33
It may also be useful for GPs to make 
contact with a patient at the time of diagnosis 
as acknowledgement of the diagnosis and 
to offer general support, thereby promoting 
an integrated approach to care.34 Integrated 
care, with seamless transitions between 
care providers, could also be facilitated by 
patient-held or electronic resources; there is 
some recent evidence for the usefulness of 
web-based survivorship care plans for adult 
survivors of childhood cancer.35,36 Although 
these approaches are all highly desirable, 
they bring with them resource implications 
for primary care. In the current context of 
English primary care struggling to meet 
current demand, and training places not 
being filled, the British Medical Association 
has recently recommended that practices 
should receive resources to provide extra 
services.37 
Although most cancer survivorship work 
has focused on people living with, and beyond, 
the most common adult cancers — namely 
breast, prostate, and colorectal cancer — 
with reasonable outcomes, survivors of 
childhood cancer are an important group 
for the number of life years gained. Most 
will seek care from primary care, which 
will need appropriate guidelines and tools 
to support that. Shared-care models have 
been piloted in the Netherlands;35 similar 
models may have value in other countries. 
GPs in remote areas may need more specific 
guidelines and tools to support shared care.
Late effects of cancer treatment on 
cardiovascular health are also becoming 
a priority area as more radiotherapy and 
combination, adjuvant, and targeted 
chemotherapies are delivered. Rapid 
improvements in outcomes from 
childhood cancer treatment have led to 
many more adult survivors at increased 
cardiovascular risk, as well as older adult 
survivors including those with pre-existing 
cardiovascular disease. This study showed 
that, although GPs often did not consider 
a previous diagnosis of cancer when 
discussing cardiovascular and bone health, 
most had an appetite for further education to 
improve their expertise in the management 
of cancer treatment-related side effects and 
cardiovascular and bone consequences. 
In conclusion, GPs need efficient tools and 
appropriate education to provide high-quality 
care for people living with the consequences 
of cancer and its treatment. Interventions 
should focus on improving communication 
between primary and secondary care, raising 
awareness of physical and psychological 
consequences, optimising existing 
resources, and enhancing knowledge of late 
effects and how best to manage them.
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